Tell your friends about this item:
Target Validation in Drug Discovery
Dillon
Target Validation in Drug Discovery
Dillon
Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.
296 pages, Illustrated
Media | Books Hardcover Book (Book with hard spine and cover) |
Released | September 1, 2006 |
ISBN13 | 9780123693938 |
Publishers | Elsevier Science Publishing Co Inc |
Pages | 296 |
Dimensions | 184 × 260 × 24 mm · 820 g |
Editor | Dillon, Susan (Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.) |
Editor | Metcalf, Brian W. (Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.) |
Show all
More by Dillon
Others have also bought
See all of Dillon ( e.g. Book , CD , LP , Hardcover Book and Paperback Book )